Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source

References

• Admyre C, Johansson SM, Qazi KR, et al. (2007). Exosomes with immune modulatory features are present in human breast milk. J Immunol 179:1969–78.
   PubMed Web of Science ®Google Scholar
• Agrawal AK, Aqil F, Jeyabalan J, et al. (2017). Milk-derived exosomes for oral delivery of paclitaxel. Nanomedicine 13:1627–36.
   PubMed Web of Science ®Google Scholar
• Akao Y, Iio A, Itoh T, et al. (2011). Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. Mol Ther 19:395–9.
   PubMed Web of Science ®Google Scholar
• Alderton GK. (2012). Exosomes drive premetastatic niche formation. Nat Rev Cancer 12:447.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. (2013). Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65:36–48.
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Seow Y, Yin H, et al. (2011). Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341–5.
   PubMed Web of Science ®Google Scholar
• Andre F, Escudier B, Angevin E, et al. (2004). Exosomes for cancer immunotherapy. Ann Oncol 15:iv141–4.
   PubMed Web of Science ®Google Scholar
• Andriolo G, Provasi E, Lo Cicero V, et al. (2018). Exosomes from human cardiac progenitor cells for therapeutic applications: development of a GMP-grade manufacturing method. Front Physiol 9:1169.
   PubMed Web of Science ®Google Scholar
• Antimisiaris SG, Mourtas S, Marazioti A. (2018). Exosomes and exosome-inspired vesicles for targeted drug delivery. Pharmaceutics 10:218.
   PubMed Web of Science ®Google Scholar
• Aqil F, Jeyabalan J, Agrawal AK, et al. (2017). Exosomal delivery of berry anthocyanidins for the management of ovarian cancer. Food Funct 8:4100–7.
   PubMed Web of Science ®Google Scholar
• Aqil F, Munagala R, Jeyabalan J, et al. (2019). Milk exosomes – natural nanoparticles for siRNA delivery. Cancer Lett 449:186–95.
   PubMed Web of Science ®Google Scholar
• Aranda-Souza MÂ, Lorena VMBd, Correia MTdS, et al. (2019). A C-type lectin from Bothrops leucurus snake venom forms amyloid-like aggregates in RPMI medium and are efficiently phagocytosed by peritoneal macrophages. Toxicon 157:93–100.
   PubMed Web of Science ®Google Scholar
• Armstrong JP, Holme MN, Stevens MM. (2017). Re-engineering extracellular vesicles as smart nanoscale therapeutics. ACS Nano 11:69–83.
   PubMed Web of Science ®Google Scholar
• Armstrong JPK, Stevens MM. (2018). Strategic design of extracellular vesicle drug delivery systems. Adv Drug Deliv Rev 130:12–6.
   PubMed Web of Science ®Google Scholar
• Aslan C, Maralbashi S, Salari F, et al. (2019). Tumor-derived exosomes: implication in angiogenesis and antiangiogenesis cancer therapy. J Cell Physiol 234:16885–903.
   PubMed Web of Science ®Google Scholar
• Babst M, Odorizzi G, Estepa EJ, et al. (2000). Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic 1:248–58.
   PubMed Web of Science ®Google Scholar
• Banas A, Teratani T, Yamamoto Y, et al. (2007). Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 46:219–28.
   PubMed Web of Science ®Google Scholar
• Bangham AD, Horne R. (1964). Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J Mol Biol 8:660–8.
   PubMed Web of Science ®Google Scholar
• Barenholz Y. (2012). Doxil® — the first FDA-approved nano-drug: lessons learned. J Control Release 160:117–34.
   PubMed Web of Science ®Google Scholar
• Barile L, Vassalli G. (2017). Exosomes: therapy delivery tools and biomarkers of diseases. Pharmacol Ther 174:63–78.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Kim MS. (2015). Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release 219:396–405.
   PubMed Web of Science ®Google Scholar
• Bell BM, Kirk ID, Hiltbrunner S, et al. (2016). Designer exosomes as next-generation cancer immunotherapy. Nanomedicine 12:163–9.
   PubMed Web of Science ®Google Scholar
• Betker JL, Angle BM, Graner MW, et al. (2019). The potential of exosomes from cow milk for oral delivery. J Pharm Sci 108:1496–505.
   PubMed Web of Science ®Google Scholar
• Binenbaum Y, Fridman E, Yaari Z, et al. (2018). Transfer of miRNA in macrophage-derived exosomes induces drug resistance in pancreatic adenocarcinoma. Cancer Res 78:5287–99.
   PubMed Web of Science ®Google Scholar
• Børresen B, Henriksen JR, Clergeaud G, et al. (2018). Theranostic imaging may vaccinate against the therapeutic benefit of long circulating PEGylated liposomes and change cargo pharmacokinetics. ACS Nano 12:11386–98.
   PubMed Web of Science ®Google Scholar
• Bose RJC, Uday Kumar S, Zeng Y, et al. (2018). Tumor cell-derived extracellular vesicle-coated nanocarriers: an efficient theranostic platform for the cancer-specific delivery of anti-miR-21 and imaging agents. ACS Nano 12:10817–32.
   PubMed Web of Science ®Google Scholar
• Bunggulawa EJ, Wang W, Yin T, et al. (2018). Recent advancements in the use of exosomes as drug delivery systems. J Nanobiotechnol 16:81.
   PubMed Web of Science ®Google Scholar
• Buzas EI, György B, Nagy G, et al. (2014). Emerging role of extracellular vesicles in inflammatory diseases. Nat Rev Rheumatol 10:356–64.
   PubMed Web of Science ®Google Scholar
• Casella G, Colombo F, Finardi A, et al. (2018). Extracellular vesicles containing IL-4 modulate neuroinflammation in a mouse model of multiple sclerosis. Mol Ther 26:2107–18.
   PubMed Web of Science ®Google Scholar
• Chen DS, Mellman I. (2013). Oncology meets immunology: the cancer-immunity cycle. Immunity 39:1–10.
   PubMed Web of Science ®Google Scholar
• Cheng L, Wang Y, Huang L. (2017). Exosomes from M1-polarized macrophages potentiate the cancer vaccine by creating a pro-inflammatory microenvironment in the lymph node. Mol Ther 25:1665–75.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Shi X, Han M, et al. (2018a). Reprogramming exosomes as nanoscale controllers of cellular immunity. J Am Chem Soc 140:16413–7.
   PubMed Web of Science ®Google Scholar
• Cheng X, Zhang G, Zhang L, et al. (2018b). Mesenchymal stem cells deliver exogenous miR-21 via exosomes to inhibit nucleus pulposus cell apoptosis and reduce intervertebral disc degeneration. J Cell Mol Med 22:261–76.
   PubMed Web of Science ®Google Scholar
• Choi SA, Lee JY, Kwon SE, et al. (2015). Human adipose tissue-derived mesenchymal stem cells target brain tumor-initiating cells. PLoS One 10:e0129292.
   PubMed Web of Science ®Google Scholar
• Clayton A, Harris C L, Court J, et al. (2003). Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur J Immunol 33:522–31.
   PubMed Web of Science ®Google Scholar
• Clayton A, Mason MD. (2009). Exosomes in tumour immunity. Curr Oncol 16:46–9.
   PubMed Web of Science ®Google Scholar
• Cocucci E, Racchetti G, Meldolesi J. (2009). Shedding microvesicles: artefacts no more. Trends Cell Biol 19:43–51.
   PubMed Web of Science ®Google Scholar
• Colombo M, Raposo G, Thery C. (2014). Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255–89.
   PubMed Web of Science ®Google Scholar
• Cooper JM, Wiklander PBO, Nordin JZ, et al. (2014). Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov Disord 29:1476–85.
   PubMed Web of Science ®Google Scholar
• Das CK, Jena BC, Banerjee I, et al. (2019). Exosome as a novel shuttle for delivery of therapeutics across biological barriers. Mol Pharm 16:24–40.
   PubMed Web of Science ®Google Scholar
• De Jong WH, Borm P. (2008). Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine 3:133–49.
   PubMed Web of Science ®Google Scholar
• Didiot M-C, Hall LM, Coles AH, et al. (2016). Exosome-mediated delivery of hydrophobically modified siRNA for Huntingtin mRNA silencing. Mol Ther 24:1836–47.
   PubMed Web of Science ®Google Scholar
• Dragovic RA, Gardiner C, Brooks AS, et al. (2011). Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomedicine 7:780–8.
   PubMed Web of Science ®Google Scholar
• El-Andaloussi S, Lee Y, Lakhal-Littleton S, et al. (2012). Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc 7:2112–26.
   PubMed Web of Science ®Google Scholar
• EL Andaloussi S, Mäger I, Breakefield XO, Wood MJ. (2013). Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 12:347–57.
   PubMed Web of Science ®Google Scholar
• Fan Y, Zhang Q. (2013). Development of liposomal formulations: from concept to clinical investigations. Asian J Pharm Sci 8:81–7.
   Google Scholar
• Ferguson SW, Nguyen J. (2016). Exosomes as therapeutics: the implications of molecular composition and exosomal heterogeneity. J Control Release 228:179–90.
   PubMed Web of Science ®Google Scholar
• Fernandez-Fernandez A, Manchanda R, McGoron AJ. (2011). Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. Appl Biochem Biotechnol 165:1628–51.
   PubMed Web of Science ®Google Scholar
• Fuhrmann G, Serio A, Mazo M, et al. (2015). Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release 205:35–44.
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Ciernik IF, Carbone DP. (1996). Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts. Cell Immunol 170:101–10.
   PubMed Web of Science ®Google Scholar
• Gardiner C, Vizio DD, Sahoo S, et al. (2016). Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J Extracell Vesicles 5:32945.
   PubMed Web of Science ®Google Scholar
• Gargiulo E, Paggetti J, Moussay E. (2019). Hematological malignancy-derived small extracellular vesicles and tumor microenvironment: the art of turning foes into friends. Cells 8:511.
   PubMed Web of Science ®Google Scholar
• Garofalo M, Villa A, Rizzi N, et al. (2019). Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice. J Control Release 294:165–75.
   PubMed Web of Science ®Google Scholar
• Götherström C, Ringdén O, Westgren M, et al. (2003). Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells. Bone Marrow Transplant 32:265–72.
   PubMed Web of Science ®Google Scholar
• Gregoire V, Langendijk JA, Nuyts S. (2015). Advances in radiotherapy for head and neck cancer. J Clin Oncol 33:3277–84.
   PubMed Web of Science ®Google Scholar
• Gruenberg J, Maxfield FR. (1995). Membrane transport in the endocytic pathway. Curr Opin Cell Biol 7:552–63.
   PubMed Web of Science ®Google Scholar
• Gudbergsson JM, Jønsson K, Simonsen JB, et al. (2019). Systematic review of targeted extracellular vesicles for drug delivery – considerations on methodological and biological heterogeneity. J Control Release 306:108–20.
   PubMed Web of Science ®Google Scholar
• Gulati M, Grover M, Singh S, et al. (1998). Lipophilic drug derivatives in liposomes. Int J Pharm 165:129–68.
   Web of Science ®Google Scholar
• Guo M, Wu F, Hu G, et al. (2019). Autologous tumor cell-derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion. Sci Transl Med 11:eaat5690.
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Kang M-H, Jeyaraj M, et al. (2019). Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells 8:307.
   PubMed Web of Science ®Google Scholar
• Han Q, Zhao H, Jiang Y, et al. (2019). HCC-derived exosomes: critical player and target for cancer immune escape. Cells 8:558.
   PubMed Web of Science ®Google Scholar
• Haney MJ, Klyachko NL, Zhao Y, et al. (2015). Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release 207:18–30.
   PubMed Web of Science ®Google Scholar
• Haraszti RA, Miller R, Stoppato M, et al. (2018). Exosomes produced from 3D cultures of MSCs by tangential flow filtration show higher yield and improved activity. Mol Ther 26:2838–47.
   PubMed Web of Science ®Google Scholar
• Harding C, Heuser J, Stahl P. (1984). Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: demonstration of a pathway for receptor shedding. Eur J Cell Biol 35:256–63.
   PubMed Web of Science ®Google Scholar
• Hartjes T, Mytnyk S, Jenster G, et al. (2019). Extracellular vesicle quantification and characterization: common methods and emerging approaches. Bioengineering (Basel) 6:7.
   PubMed Web of Science ®Google Scholar
• Haug A, Hostmark AT, Harstad OM. (2007). Bovine milk in human nutrition – a review. Lipids Health Dis 6:25.
   PubMed Web of Science ®Google Scholar
• He C, Zheng S, Luo Y, et al. (2018). Exosome theranostics: biology and translational medicine. Theranostics 8:237–55.
   PubMed Web of Science ®Google Scholar
• Hong Y, Nam G-H, Koh E, et al. (2018). Exosome as a vehicle for delivery of membrane protein therapeutics, PH20, for enhanced tumor penetration and antitumor efficacy. Adv Funct Mater 28:1703074.
   Web of Science ®Google Scholar
• Hsiao W-C, Sung S-Y, Liao C-H, et al. (2012). Vitamin D3-inducible mesenchymal stem cell-based delivery of conditionally replicating adenoviruses effectively targets renal cell carcinoma and inhibits tumor growth. Mol Pharm 9:1396–408.
   PubMed Web of Science ®Google Scholar
• Hu W, Wang J, He X, et al. (2011). Human umbilical blood mononuclear cell-derived mesenchymal stem cells serve as interleukin-21 gene delivery vehicles for epithelial ovarian cancer therapy in nude mice. Biotechnol Appl Biochem 58:397–404.
   PubMed Web of Science ®Google Scholar
• Huang GT, Gronthos S, Shi S. (2009). Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J Dent Res 88:792–806.
   PubMed Web of Science ®Google Scholar
• Immordino ML, Dosio F, Cattel L. (2006). Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 1:297–315.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Guan J, Qian J, et al. (2019). Peptide ligand-mediated targeted drug delivery of nanomedicines. Biomater Sci 7:461–71.
   PubMed Web of Science ®Google Scholar
• Jin K, Luo Z, Zhang B, et al. (2018). Biomimetic nanoparticles for inflammation targeting. Acta Pharm Sin B 8:23–33.
   PubMed Web of Science ®Google Scholar
• Jo JI, Gao JQ, Tabata Y. (2019). Biomaterial-based delivery systems of nucleic acid for regenerative research and regenerative therapy. Regen Ther 11:123–30.
   PubMed Web of Science ®Google Scholar
• Johnsen KB, Gudbergsson JM, Duroux M, et al. (2018). On the use of liposome controls in studies investigating the clinical potential of extracellular vesicle-based drug delivery systems – a commentary. J Control Release 269:10–4.
   PubMed Web of Science ®Google Scholar
• Johnsen KB, Gudbergsson JM, Skov MN, et al. (2014). A comprehensive overview of exosomes as drug delivery vehicles – endogenous nanocarriers for targeted cancer therapy. Biochim Biophys Acta 1846:75–87.
   PubMed Web of Science ®Google Scholar
• Juliano RL. (2016). The delivery of therapeutic oligonucleotides. Nucleic Acids Res 44:6518–48.
   PubMed Web of Science ®Google Scholar
• Jung KO, Jo H, Yu JH, et al. (2018). Development and MPI tracking of novel hypoxia-targeted theranostic exosomes. Biomaterials 177:139–48.
   PubMed Web of Science ®Google Scholar
• Kalra H, Simpson RJ, Ji H, et al. (2012). Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 10:e1001450.
   PubMed Web of Science ®Google Scholar
• Kamerkar S, LeBleu VS, Sugimoto H, et al. (2017). Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 546:498–503.
   PubMed Web of Science ®Google Scholar
• Kantoff PW, Higano CS, Shore ND, et al. (2010). Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 363:411–22.
   PubMed Web of Science ®Google Scholar
• Keerthikumar S, Chisanga D, Ariyaratne D, et al. (2016). ExoCarta: a web-based compendium of exosomal cargo. J Mol Biol 428:688–92.
   PubMed Web of Science ®Google Scholar
• Kern S, Eichler H, Stoeve J, et al. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294–301.
   PubMed Web of Science ®Google Scholar
• Khan AR, Yang X, Fu M, et al. (2018). Recent progress of drug nanoformulations targeting to brain. J Control Release 291:37–64.
   PubMed Web of Science ®Google Scholar
• Kim D-K, Lee J, Kim SR, et al. (2015). EVpedia: a community web portal for extracellular vesicles research. Bioinformatics 31:933–9.
   PubMed Web of Science ®Google Scholar
• Kim MS, Haney MJ, Zhao Y, et al. (2016). Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine 12:655–64.
   PubMed Web of Science ®Google Scholar
• Kim MS, Haney MJ, Zhao Y, et al. (2018). Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations. Nanomedicine 14:195–204.
   PubMed Web of Science ®Google Scholar
• Kim SM, Oh JH, Park SA, et al. (2010). Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy. Stem Cells 28:2217–28.
   PubMed Web of Science ®Google Scholar
• Kooijmans SAA, Fliervoet LAL, van der Meel R, et al. (2016). PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. J Control Release 224:77–85.
   PubMed Web of Science ®Google Scholar
• Kourembanas S. (2015). Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu Rev Physiol 77:13–27.
   PubMed Web of Science ®Google Scholar
• Kuo WP, Tigges JC, Toxavidis V, Ghiran I. (2017). Red blood cells: a source of extracellular vesicles. Methods Mol Biol 1660:15–22.
   PubMedGoogle Scholar
• Kutova O, Guryev E, Sokolova E, et al. (2019). Targeted delivery to tumors: multidirectional strategies to improve treatment efficiency. Cancers (Basel) 11:68.
   PubMed Web of Science ®Google Scholar
• Lai RC, Arslan F, Tan SS, et al. (2010). Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles. J Mol Cell Cardiol 48:1215–24.
   PubMed Web of Science ®Google Scholar
• Lai RC, Yeo RWY, Tan KH, et al. (2013). Exosomes for drug delivery – a novel application for the mesenchymal stem cell. Biotechnol Adv 31:543–51.
   PubMed Web of Science ®Google Scholar
• Lakhal S, Wood MJ. (2011). Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers. Bioessays 33:737–41.
   PubMed Web of Science ®Google Scholar
• Lamparski HG, Metha-Damani A, Yao J-Y, et al. (2002). Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods 270:211–26.
   PubMed Web of Science ®Google Scholar
• Lang FM, Hossain A, Gumin J, et al. (2018). Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas. Neuro Oncol 20:380–90.
   PubMed Web of Science ®Google Scholar
• Lee HK, Finniss S, Cazacu S, et al. (2014). Mesenchymal stem cells deliver exogenous miRNAs to neural cells and induce their differentiation and glutamate transporter expression. Stem Cells Dev 23:2851–61.
   PubMed Web of Science ®Google Scholar
• Lee J, Kim J, Jeong M, et al. (2015). Liposome-based engineering of cells to package hydrophobic compounds in membrane vesicles for tumor penetration. Nano Lett 15:2938–44.
   PubMed Web of Science ®Google Scholar
• Lee RH, Kim B, Choi I, et al. (2004). Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14:311–24.
   PubMed Web of Science ®Google Scholar
• Li J, Hosseini-Beheshti E, Grau G, et al. (2019a). Stem cell-derived extracellular vesicles for treating joint injury and osteoarthritis. Nanomaterials (Basel) 9:261.
   PubMedGoogle Scholar
• Li L, Cao B, Liang X, et al. (2019b). Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral gammadelta T cell equilibrium via tumor-derived exosomes. Oncogene 38:2830–43.
   PubMed Web of Science ®Google Scholar
• Li L, Li C, Wang S, et al. (2016). Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype. Cancer Res 76:1770–80.
   PubMed Web of Science ®Google Scholar
• Li L, Lu S, Liang X, et al. (2019c). GammadeltaTDEs: an efficient delivery system for miR-138 with anti-tumoral and immunostimulatory roles on oral squamous cell carcinoma. Mol Ther Nucleic Acids 14:101–13.
   PubMedGoogle Scholar
• Li P, Kaslan M, Lee SH, et al. (2017). Progress in exosome isolation techniques. Theranostics 7:789–804.
   PubMed Web of Science ®Google Scholar
• Li S-p, Lin Z-x, Jiang X-y, et al. (2018). Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools. Acta Pharmacol Sin 39:542–51.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhou X, Wei M, et al. (2019d). In vitro and in vivo RNA inhibition by CD9-HuR functionalized exosomes encapsulated with miRNA or CRISPR/dCas9. Nano Lett 19:19–28.
   PubMed Web of Science ®Google Scholar
• Liao W, Du Y, Zhang C, et al. (2019). Exosomes: the next generation of endogenous nanomaterials for advanced drug delivery and therapy. Acta Biomater 86:1–14.
   PubMed Web of Science ®Google Scholar
• Limoni SK, Moghadam MF, Moazzeni SM, et al. (2019). Engineered exosomes for targeted transfer of siRNA to HER2 positive breast cancer cells. Appl Biochem Biotechnol 187:352–64.
   PubMed Web of Science ®Google Scholar
• Lin Y, Wu J, Gu W, et al. (2018). Exosome-liposome hybrid nanoparticles deliver CRISPR/Cas9 system in MSCs. Adv Sci 5:1700611.
   Web of Science ®Google Scholar
• Liu C, Feng Q, Sun J. (2019). Lipid nanovesicles by microfluidics: manipulation, synthesis, and drug delivery. Adv Mater 31:e1804788.
   PubMed Web of Science ®Google Scholar
• Liu H, Chen L, Liu J, et al. (2017). Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma. Cancer Lett 411:182–90.
   PubMed Web of Science ®Google Scholar
• Lu J, Wu J, Tian J, et al. (2018). Role of T cell-derived exosomes in immunoregulation. Immunol Res 66:313–22.
   PubMed Web of Science ®Google Scholar
• Luan X, Sansanaphongpricha K, Myers I, et al. (2017). Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin 38:754–63.
   PubMed Web of Science ®Google Scholar
• Lynch S, Santos SG, Campbell EC, et al. (2009). Novel MHC class I structures on exosomes. J Immunol 183:1884–91.
   PubMed Web of Science ®Google Scholar
• Mahaweni NM, Kaijen-Lambers ME, Dekkers J, et al. (2013). Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma. J Extracell Vesicles 2.
   Google Scholar
• Mancuso P, Raman S, Glynn A, et al. (2019). Mesenchymal stem cell therapy for osteoarthritis: the critical role of the cell secretome. Front Bioeng Biotechnol 7:9.
   PubMed Web of Science ®Google Scholar
• Mannavola F, Tucci M, Felici C, et al. (2019). Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis. J Transl Med 17:230.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Marchesi F, Malesci A, et al. (2017). Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14:399–416.
   PubMed Web of Science ®Google Scholar
• Melnik BC, John SM, Schmitz G. (2014). Milk: an exosomal microRNA transmitter promoting thymic regulatory T cell maturation preventing the development of atopy? J Transl Med 12:43.
   PubMed Web of Science ®Google Scholar
• Mendt M, Kamerkar S, Sugimoto H, et al. (2018). Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight 3:99263.
   PubMed Web of Science ®Google Scholar
• Meng W, Hao Y, He C, et al. (2019). Exosome-orchestrated hypoxic tumor microenvironment. Mol Cancer 18:57.
   PubMed Web of Science ®Google Scholar
• Merchant ML, Rood IM, Deegens JKJ, et al. (2017). Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery. Nat Rev Nephrol 13:731–49.
   PubMed Web of Science ®Google Scholar
• Miao Z, Jin J, Chen L, et al. (2006). Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 30:681–7.
   PubMed Web of Science ®Google Scholar
• Mignot G, Roux S, Thery C, et al. (2006). Prospects for exosomes in immunotherapy of cancer. J Cell Mol Med 10:376–88.
   PubMed Web of Science ®Google Scholar
• Momen-Heravi F, Balaj L, Alian S, et al. (2013). Current methods for the isolation of extracellular vesicles. Biol Chem 394:1253–62.
   PubMed Web of Science ®Google Scholar
• Moris D, Beal EW, Chakedis J, et al. (2017). Role of exosomes in treatment of hepatocellular carcinoma. Surg Oncol 26:219–228.
   PubMed Web of Science ®Google Scholar
• Munagala R, Aqil F, Jeyabalan J, et al. (2016). Bovine milk-derived exosomes for drug delivery. Cancer Lett 371:48–61.
   PubMed Web of Science ®Google Scholar
• Munoz JL, Bliss SA, Greco SJ, et al. (2013). Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Mol Ther Nucleic Acids 2:e126.
   PubMedGoogle Scholar
• Nakamura K, Ito Y, Kawano Y, et al. (2004). Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 11:1155–64.
   PubMed Web of Science ®Google Scholar
• Nakase I, Futaki S. (2015). Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes. Sci Rep 5:10112.
   PubMed Web of Science ®Google Scholar
• Nogueira E, Gomes AC, Preto A, et al. (2015). Design of liposomal formulations for cell targeting. Colloids Surf B Biointerfaces 136:514–26.
   PubMed Web of Science ®Google Scholar
• Nonaka T, Wong DTW. (2017). Saliva-exosomics in cancer: molecular characterization of cancer-derived exosomes in saliva. Enzymes 42:125–51.
   PubMedGoogle Scholar
• Ohno S, Drummen GPC, Kuroda M. (2016). Focus on extracellular vesicles: development of extracellular vesicle-based therapeutic systems. Int J Mol Sci 17:172.
   PubMed Web of Science ®Google Scholar
• Ohno S-i, Takanashi M, Sudo K, et al. (2013). Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 21:185–91.
   PubMed Web of Science ®Google Scholar
• Pachler K, Lener T, Streif D, et al. (2017). A good manufacturing practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles. Cytotherapy 19:458–72.
   PubMed Web of Science ®Google Scholar
• Palazzolo S, Bayda S, Hadla M, et al. (2018). The clinical translation of organic nanomaterials for cancer therapy: a focus on polymeric nanoparticles. Curr Med Chem 25:4224–68.
   PubMed Web of Science ®Google Scholar
• Pan BT, Johnstone RM. (1983). Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33:967–78.
   PubMed Web of Science ®Google Scholar
• Pascucci L, Coccè V, Bonomi A, et al. (2014). Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release 192:262–70.
   PubMed Web of Science ®Google Scholar
• Perets N, Betzer O, Shapira R, et al. (2019). Golden exosomes selectively target brain pathologies in neurodegenerative and neurodevelopmental disorders. Nano Lett 19:3422–31.
   PubMed Web of Science ®Google Scholar
• Pessina A, Bonomi A, Coccè V, et al. (2011). Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy. PLoS One 6:e28321.
   PubMed Web of Science ®Google Scholar
• Phan J, Kumar P, Hao D, et al. (2018). Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy. J Extracell Vesicles 7:1522236.
   PubMed Web of Science ®Google Scholar
• Piffoux M, Nicolás-Boluda A, Mulens-Arias V, et al. (2019). Extracellular vesicles for personalized medicine: the input of physically triggered production, loading and theranostic properties. Adv Drug Deliv Rev 138:247–58.
   PubMed Web of Science ®Google Scholar
• Pitt JM, André F, Amigorena S, et al. (2016). Dendritic cell-derived exosomes for cancer therapy. J Clin Invest 126:1224–32.
   PubMed Web of Science ®Google Scholar
• Pitt JM, Charrier M, Viaud S, et al. (2014). Dendritic cell-derived exosomes as immunotherapies in the fight against cancer. J Immunol 193:1006–11.
   PubMed Web of Science ®Google Scholar
• Poggio M, Hu T, Pai C-C, et al. (2019). Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory. Cell 177:414–27.e13.
   PubMed Web of Science ®Google Scholar
• Poon IKH, Lucas CD, Rossi AG, et al. (2014). Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol 14:166–80.
   PubMed Web of Science ®Google Scholar
• Pullan JE, Confeld MI, Osborn JK, et al. (2019). Exosomes as drug carriers for cancer therapy. Mol Pharm 16:1789–98.
   PubMed Web of Science ®Google Scholar
• Qiu X, Li Z, Han X, et al. (2019). Tumor-derived nanovesicles promote lung distribution of the therapeutic nanovector through repression of Kupffer cell-mediated phagocytosis. Theranostics 9:2618–36.
   PubMed Web of Science ®Google Scholar
• Rahbarghazi R, Jabbari N, Sani NA, et al. (2019). Tumor-derived extracellular vesicles: reliable tools for cancer diagnosis and clinical applications. Cell Commun Signal 17:73.
   PubMed Web of Science ®Google Scholar
• Rao L, Cai B, Bu L-L, et al. (2017). Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy. ACS Nano 11:3496–505.
   PubMed Web of Science ®Google Scholar
• Riazifar M, Mohammadi MR, Pone EJ, et al. (2019). Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders. ACS Nano 13:6670–88.
   PubMed Web of Science ®Google Scholar
• Roubelakis MG, Pappa KI, Bitsika V, et al. (2007). Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 16:931–52.
   PubMed Web of Science ®Google Scholar
• Rufino-Ramos D, Albuquerque PR, Carmona V, et al. (2017). Extracellular vesicles: novel promising delivery systems for therapy of brain diseases. J Control Release 262:247–58.
   PubMed Web of Science ®Google Scholar
• Ruivo CF, Adem B, Silva M, Melo SA. (2017). The biology of cancer exosomes: insights and new perspectives. Cancer Res 77:6480–8.
   PubMed Web of Science ®Google Scholar
• Sabado RL, Balan S, Bhardwaj N. (2017). Dendritic cell-based immunotherapy. Cell Res 27:74–95.
   PubMed Web of Science ®Google Scholar
• Sato T, Iso Y, Uyama T, et al. (2011). Coronary vein infusion of multipotent stromal cells from bone marrow preserves cardiac function in swine ischemic cardiomyopathy via enhanced neovascularization. Lab Invest 91:553–64.
   PubMed Web of Science ®Google Scholar
• Segura E, Amigorena S, Thery C. (2005). Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells Mol Dis 35:89–93.
   PubMed Web of Science ®Google Scholar
• Seo N, Shirakura Y, Tahara Y, et al. (2018). Activated CD8(+) T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells. Nat Commun 9:435.
   PubMed Web of Science ®Google Scholar
• Sharif S, Ghahremani MH, Soleimani M. (2018). Delivery of exogenous miR-124 to glioblastoma multiform cells by Wharton’s jelly mesenchymal stem cells decreases cell proliferation and migration, and confers chemosensitivity. Stem Cell Rev and Rep 14:236–46.
   PubMed Web of Science ®Google Scholar
• Shi M, Sheng L, Stewart T, et al. (2019). New windows into the brain: central nervous system-derived extracellular vesicles in blood. Prog Neurobiol 175:96–106.
   PubMed Web of Science ®Google Scholar
• Smyth T, Kullberg M, Malik N, et al. (2015). Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release 199:145–55.
   PubMed Web of Science ®Google Scholar
• Steinman RM. (2012). Decisions about dendritic cells: past, present, and future. Annu Rev Immunol 30:1–22.
   PubMed Web of Science ®Google Scholar
• Stranska R, Gysbrechts L, Wouters J, et al. (2018). Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma. J Transl Med 16:1.
   PubMed Web of Science ®Google Scholar
• Street JM, Koritzinsky EH, Glispie DM, et al. (2017). Urine exosomes: an emerging trove of biomarkers. Adv Clin Chem 78:103–22.
   PubMed Web of Science ®Google Scholar
• Sun D, Zhuang X, Xiang X, et al. (2010). A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther 18:1606–14.
   PubMed Web of Science ®Google Scholar
• Sun W, Luo J-d, Jiang H, et al. (2018). Tumor exosomes: a double-edged sword in cancer therapy. Acta Pharmacol Sin 39:534–41.
   PubMed Web of Science ®Google Scholar
• Sun X-l, Xu Z-m, Ke Y-q, et al. (2011). Molecular targeting of malignant glioma cells with an EphA2-specific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells. Cancer Lett 312:168–77.
   PubMed Web of Science ®Google Scholar
• Teng Y, Ren Y, Hu X, et al. (2017). MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression. Nat Commun 8:14448.
   PubMed Web of Science ®Google Scholar
• Thakur BK, Zhang H, Becker A, et al. (2014). Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res 24:766–9.
   PubMed Web of Science ®Google Scholar
• Thery C. (2015). Cancer: diagnosis by extracellular vesicles. Nature 523:161–2.
   PubMed Web of Science ®Google Scholar
• Thery C, Amigorena S, Raposo G, Clayton A. (2006). Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. doi: 10.1002/0471143030.cb0322s30.
   PubMedGoogle Scholar
• Thery C, Ostrowski M, Segura E. (2009). Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9:581–93.
   PubMed Web of Science ®Google Scholar
• Thery C, Regnault A, Garin J, et al. (1999). Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol 147:599–610.
   PubMed Web of Science ®Google Scholar
• Théry C, Witwer KW, Aikawa E, et al. (2018). Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7:1535750.
   PubMed Web of Science ®Google Scholar
• Thery C, Zitvogel L, Amigorena S. (2002). Exosomes: composition, biogenesis and function. Nat Rev Immunol 2:569–79.
   PubMed Web of Science ®Google Scholar
• Tian T, Zhang H-X, He C-P, et al. (2018). Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials 150:137–49.
   PubMed Web of Science ®Google Scholar
• Tian Y, Li S, Song J, et al. (2014). A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35:2383–90.
   PubMed Web of Science ®Google Scholar
• Tkach M, Théry C. (2016). Communication by extracellular vesicles: where we are and where we need to go. Cell 164:1226–32.
   PubMed Web of Science ®Google Scholar
• Torchilin V. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–60.
   PubMed Web of Science ®Google Scholar
• Usman WM, Pham TC, Kwok YY, et al. (2018). Efficient RNA drug delivery using red blood cell extracellular vesicles. Nat Commun 9:2359.
   PubMed Web of Science ®Google Scholar
• Vader P, Mol EA, Pasterkamp G, et al. (2016). Extracellular vesicles for drug delivery. Adv Drug Deliv Rev 106:148–56.
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekström K, Bossios A, et al. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654–9.
   PubMed Web of Science ®Google Scholar
• van den Boorn JG, Schlee M, Coch C, et al. (2011). SiRNA delivery with exosome nanoparticles. Nat Biotechnol 29:325–6.
   PubMed Web of Science ®Google Scholar
• van der Meel R, Fens M, Vader P, et al. (2014). Extracellular vesicles as drug delivery systems: lessons from the liposome field. J Control Release 195:72–85.
   PubMed Web of Science ®Google Scholar
• van Niel G, D'Angelo G, Raposo G. (2018). Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19:213–28.
   PubMed Web of Science ®Google Scholar
• Vashisht M, Rani P, Onteru SK, et al. (2017). Curcumin encapsulated in milk exosomes resists human digestion and possesses enhanced intestinal permeability in vitro. Appl Biochem Biotechnol 183:993–1007.
   PubMed Web of Science ®Google Scholar
• Vergauwen G, Dhondt B, Van Deun J, et al. (2017). Confounding factors of ultrafiltration and protein analysis in extracellular vesicle research. Sci Rep 7:2704.
   PubMed Web of Science ®Google Scholar
• Vermeer PD. (2019). Exosomal induction of tumor innervation. Cancer Res 79:3529–35.
   PubMed Web of Science ®Google Scholar
• Wen D, Peng Y, Liu D, et al. (2016). Mesenchymal stem cell and derived exosome as small RNA carrier and immunomodulator to improve islet transplantation. J Control Release 238:166–75.
   PubMed Web of Science ®Google Scholar
• Wiklander OPB, Nordin JZ, O'Loughlin A, et al. (2015). Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles 4:26316.
   PubMed Web of Science ®Google Scholar
• Wolfers J, Lozier A, Raposo G, et al. (2001). Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7:297–303.
   PubMed Web of Science ®Google Scholar
• Yang B, Chen Y, Shi J. (2019). Exosome biochemistry and advanced nanotechnology for next-generation theranostic platforms. Adv Mater 31:e1802896.
   PubMed Web of Science ®Google Scholar
• Yang M, Chen J, Su F, et al. (2011). Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer 10:117.
   PubMed Web of Science ®Google Scholar
• Yang Y, Tai X, Shi K, et al. (2016). A new concept of enhancing immuno-chemotherapeutic effects against B16F10 tumor via systemic administration by taking advantages of the limitation of EPR effect. Theranostics 6:2141–60.
   PubMed Web of Science ®Google Scholar
• Yao K, Ricardo SD. (2016). Mesenchymal stem cells as novel micro-ribonucleic acid delivery vehicles in kidney disease. Nephrology (Carlton) 21:363–71.
   PubMed Web of Science ®Google Scholar
• Yao Y, Chen L, Wei W, et al. (2013). Tumor cell-derived exosome-targeted dendritic cells stimulate stronger CD8+ CTL responses and antitumor immunities. Biochem Biophys Res Commun 436:60–5.
   PubMed Web of Science ®Google Scholar
• Yuan D, Zhao Y, Banks WA, et al. (2017). Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain. Biomaterials 142:1–12.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yin Y, Lai RC, Lim SK. (2014a). Immunotherapeutic potential of extracellular vesicles. Front Immunol 5:518.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yin Y, Lai RC, et al. (2014b). Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev 23:1233–44.
   PubMed Web of Science ®Google Scholar
• Zhang K, Zhao X, Chen X, et al. (2018a). Enhanced therapeutic effects of mesenchymal stem cell-derived exosomes with an injectable hydrogel for hindlimb ischemia treatment. ACS Appl Mater Interfaces 10:30081–91.
   PubMed Web of Science ®Google Scholar
• Zhang K-L, Wang Y-J, Sun J, et al. (2019). Artificial chimeric exosomes for anti-phagocytosis and targeted cancer therapy. Chem Sci 10:1555–61.
   PubMed Web of Science ®Google Scholar
• Zhang P, Zhang L, Qin Z, et al. (2018b). Genetically engineered liposome-like nanovesicles as active targeted transport platform. Adv Mater 30. doi: 10.1002/adma.201705350.
   Web of Science ®Google Scholar
• Zheng M, Huang M, Ma X, et al. (2019). Harnessing exosomes for the development of brain drug delivery systems. Bioconjug Chem 30:994–1005.
   PubMed Web of Science ®Google Scholar
• Zhu L, Oh JM, Gangadaran P, et al. (2018). Targeting and therapy of glioblastoma in a mouse model using exosomes derived from natural killer cells. Front Immunol 9:824.
   PubMed Web of Science ®Google Scholar
• Zhu L, Kalimuthu S, Gangadaran P, et al. (2017). Exosomes derived from natural killer cells exert therapeutic effect in melanoma. Theranostics 7:2732–45.
   PubMed Web of Science ®Google Scholar
• Zhuang X, Xiang X, Grizzle W, et al. (2011). Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 19:1769–79.
   PubMed Web of Science ®Google Scholar
• Zolnik BS, González-Fernández Á, Sadrieh N, et al. (2010). Minireview: nanoparticles and the immune system. Endocrinology 151:458–65.
   PubMed Web of Science ®Google Scholar